Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
NVCR Stock — NovoCure Limited
NovoCure Limited (NVCR)
Updated October 16, 2026.
NVCR is a Stock. Total return is -23.0% over the past 11 years, 391.2 points behind SPY at 368.2%.
NovoCure Limited is an oncology company that develops, manufactures, and commercializes tumor treating fields (TTFields) devices for treating solid tumor cancers, with marketed products including Optune Gio, Optune Lua, and Optune Pax, alongside clinical-stage programs exploring applications in brain metastases, gastric cancer, glioblastoma, liver cancer, lung cancer, pancreatic cancer, and ovarian cancer. The company does not currently have an established distribution schedule. This security appeals primarily to investors seeking exposure to oncology innovation and medical device development rather than income generation.
NVCR performance versus SPY
Price and return data through 2026-10-16.
Total return is -23.0% over the past 11 years, 391.2 points behind SPY at 368.2%. Over the past year its total return — price change plus distributions reinvested — is 0.3%. Its deepest 1-year drawdown was 32.5%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -13.3% | — |
| 3M | -14.3% | — |
| 6M | 11.5% | — |
| YTD | 8.8% | — |
| 1Y | 0.3% | — |
| 2Y CAGR | — | -11.30% |
| 3Y CAGR | — | -2.60% |
| 5Y CAGR | — | -34.00% |
| 10Y CAGR | — | 6.70% |
| Since inception (11 years) | -23.0% | -2.30% |
NVCR key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 10/02/2015
- Distribution frequency
- None
- Last close
- $14.07 (as of 2026-10-16)
- Market cap
- $1,638,392,969
- Average volume
- 1287602.0
- Beta
- 0.988
- Payout ratio
- 0.0%
- Forward P/E
- 909.0909
- EPS
- $-1.26
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
NVCR risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 32.5%.
Who may consider NVCR — and who may not
It is a weaker fit for investors who need monthly cash flow (NVCR does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on NVCR
Frequently asked questions
Does NVCR pay monthly?
No. NVCR does not currently distribute.
When does NVCR pay a dividend?
NVCR does not currently distribute.
How has NVCR performed?
Total return is -23.0% over the past 11 years, 391.2 points behind SPY at 368.2%. Over the past year its total return — price change plus distributions reinvested — is 0.3%. Its deepest 1-year drawdown was 32.5%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.